Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Withdrawn × Resectable Non-Small Cell Lung Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 95 Carcinoma, Non-Small-Cell Lung 85 Multiple Myeloma 58 Prostatic Neoplasms 56 Neoplasm Metastasis 55 Colorectal Neoplasms 55 Neoplasms 50 Leukemia, Myeloid, Acute 38 Recurrence 36 Lung Neoplasms 35 Carcinoma, Hepatocellular 34 Melanoma 29 Lymphoma 29 Leukemia, Lymphocytic, Chronic, B-Cell 29 Pancreatic Neoplasms 26 Head and Neck Neoplasms 23 Squamous Cell Carcinoma of Head and Neck 22 Rectal Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 22 Glioblastoma 22 Leukemia 21 Ovarian Neoplasms 20 Myelodysplastic Syndromes 19 Hematologic Neoplasms 19 Carcinoma, Renal Cell 18 Brain Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Colonic Neoplasms 17 Uterine Cervical Neoplasms 15 Sarcoma 15

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡